Charles Russell Speechlys has advised the owners of The Centre for Reproductive and Genetic Health (CRGH) on its sale to FutureLife.
Charles Russell Speechlys has advised the owners of CRGH, London’s largest private fertility clinic, on its majority stake sale to FutureLife.
FutureLife is a leading European IVF clinic, backed by CVC and Hartenberg Capital. This transaction will provide a strategic growth platform for FutureLife and CRGH, building on CRGH’s core value of clinical excellence.
FutureLife is one of Europe’s fastest-growing reproduction providers, with over 35 clinics across the globe in eight countries. This transaction expands FutureLife’s presence in the UK IVF market and continues its journey to becoming a pre-eminent provider in IVF treatment.
Founded by IVF pioneer and world-leading fertility expert Dr Paul Serhal, CRGH is the largest private fertility clinic in the London IVF market, performing more than 3,200 egg collections per year. CRGH are well known for delivering excellent clinical service and treatment for their clients.
Corporate Partner Michael Lingens commented: “We were delighted to work with the CRGH team on this transaction. We wish both businesses every success, and look forward to seeing the future growth of CRGH as a part of the FutureLife group.”
The Charles Russell Speechlys team was led by Partner Michael Lingens, and supported by Senior Associate Nathan Lightman, Associate Jeff Carvell, and Trainee Marc-us Ong. Real Estate Partner Mark White, led on the real estate elements of the transaction.
